AIRE-2 Device for Study of Breath Analysis in IBD

Recruiting N/A Interventional Study
Inflammatory Bowel Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
60 (estimated)
Sponsor
McMaster University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this Prospective single-blinded intervention feasibility study is the utilization of the AIRE-2 device and FoodMarble app to elucidate the interplay among diet, symptoms, and microbial fermentable features in IBD patients with persistent intestinal symptoms and their household controls. AIRE-2 captures exhaled hydrogen and methane and FoodMarble app records breath levels, symptoms and…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria (IBD): * Age 18-75 years old, confirmed diagnosis of IBD (UC or CD) * Under clinical remission for at least 3 months * Report having one or more IBS-like symptom (abdominal pain, altered bowel habit, flatulence, abdominal distension etc) * Own a smartphone with Bluetooth capabili…
Contacts

Anam Ahmed

9055212100

ahmea195@mcmaster.ca

CONTACT